OBJECTIVE: To determine whether increased levels of maternal serum total activin A and inhibin A in preeclampsia are related to total blood volume, urinary clearance, or placental production. STUDY DESIGN: Activin A and inhibin A levels were measured in preeclamptic subjects and matched normotensive gravidas. In a subset of preeclamptic subjects (n = 21) and controls (n = 30), we performed blood volume studies. In an overlapping subset of preeclamptic subjects (n = 56), creatinine clearance results were available. Placental tissue was obtained from six preeclamptics and matched normotensive gravida for analysis of activin A and inhibin A mRNA expression. RESULTS: Maternal serum levels of inhibin A but not activin A were significantly negati...
(Correspondence should be addressed to S Muttukrishna) Objective: The feto-placental unit is the maj...
OBJECTIVE: To determine whether second-trimester maternal serum levels of inhibin A, human chorioni...
BACKGROUND: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine...
OBJECTIVE: To determine whether increased levels of maternal serum total activin A and inhibin A in...
OBJECTIVE: To determine whether maternal serum activin A, inhibin A, and follistatin concentrations ...
Activin A (beta A beta A) and inhibin A (alpha beta A) are dimeric glycoproteins secreted from early...
OBJECTIVE: To evaluate whether activin A, inhibin A, and inhibin B levels in maternal and umbilica...
Objective: To investigate whether the reported increase in maternal serum activin A concentration in...
Context: The pregnancy-specific disorder preeclampsia is a major cause of maternal mortality and mor...
Objective: The purpose of this study was to determine whether, in women who are at high risk of the ...
Objectives: Previous data have shown that inhibin A (alpha/betaA) is increased about twofold in mate...
OBJECTIVE: To compare maternal serum levels of total activin A and inhibin A in preterm and term pat...
Inhibin-related proteins are involved in the control of the feto-maternal communication required to ...
Background: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine...
OBJECTIVE: Maternal serum inhibin A and activin A are higher in pre-eclampsia than in normal pregnan...
(Correspondence should be addressed to S Muttukrishna) Objective: The feto-placental unit is the maj...
OBJECTIVE: To determine whether second-trimester maternal serum levels of inhibin A, human chorioni...
BACKGROUND: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine...
OBJECTIVE: To determine whether increased levels of maternal serum total activin A and inhibin A in...
OBJECTIVE: To determine whether maternal serum activin A, inhibin A, and follistatin concentrations ...
Activin A (beta A beta A) and inhibin A (alpha beta A) are dimeric glycoproteins secreted from early...
OBJECTIVE: To evaluate whether activin A, inhibin A, and inhibin B levels in maternal and umbilica...
Objective: To investigate whether the reported increase in maternal serum activin A concentration in...
Context: The pregnancy-specific disorder preeclampsia is a major cause of maternal mortality and mor...
Objective: The purpose of this study was to determine whether, in women who are at high risk of the ...
Objectives: Previous data have shown that inhibin A (alpha/betaA) is increased about twofold in mate...
OBJECTIVE: To compare maternal serum levels of total activin A and inhibin A in preterm and term pat...
Inhibin-related proteins are involved in the control of the feto-maternal communication required to ...
Background: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine...
OBJECTIVE: Maternal serum inhibin A and activin A are higher in pre-eclampsia than in normal pregnan...
(Correspondence should be addressed to S Muttukrishna) Objective: The feto-placental unit is the maj...
OBJECTIVE: To determine whether second-trimester maternal serum levels of inhibin A, human chorioni...
BACKGROUND: Maternal circulating levels of anti-angiogenic factors such as soluble fms-like tyrosine...